Clinical Trials

Use of Tamoxifen in Systemic Mastocytosis

Location:

Rochester,  MN

Trial status:

Open for Enrollment

Why is this study being done?

Not desired

Who is eligible to participate?

Inclusion Criteria:

- Systemic Mastocytosis

Exclusion Criteria:

- Current treatment with Imatinib mesylate, cladribine or interferon alpha.

Last updated: 01/16/2013

NCT ID:

NCT01334996